Ligand Pharmaceuticals
LGND
#3638
Rank
โ‚น325.91 B
Marketcap
โ‚น16,559
Share price
-0.49%
Change (1 day)
62.13%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚น47.61 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are โ‚น47.61 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น9.55 B32.94%
2023-12-31โ‚น7.18 B-47.44%
2022-12-31โ‚น13.66 B-61.45%
2021-12-31โ‚น35.46 B-25.72%
2020-12-31โ‚น47.73 B-8%
2019-12-31โ‚น51.89 B6.04%
2018-12-31โ‚น48.93 B203.69%
2017-12-31โ‚น16.11 B2.77%
2016-12-31โ‚น15.67 B4.33%
2015-12-31โ‚น15.02 B1.5%
2014-12-31โ‚น14.80 B334.96%
2013-12-31โ‚น3.40 B-20.06%
2012-12-31โ‚น4.25 B-28.38%
2011-12-31โ‚น5.94 B65.02%
2010-12-31โ‚น3.60 B-43.76%
2009-12-31โ‚น6.40 B-26.69%
2008-12-31โ‚น8.73 B54.46%
2007-12-31โ‚น5.65 B-57.23%
2006-12-31โ‚น13.22 B-30.83%
2005-12-31โ‚น19.12 B8.3%
2004-12-31โ‚น17.66 B10.32%
2003-12-31โ‚น16.00 B65.74%
2002-12-31โ‚น9.65 B14.16%
2001-12-31โ‚น8.46 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
โ‚น7.281 T 15,190.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚น7.31 B-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น5.541 T 11,537.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น7.020 T 14,643.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น10.456 T 21,858.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น8.236 T 17,196.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น7.079 T 14,766.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚น1.252 T 2,530.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น10.266 T 21,460.73%๐Ÿ‡บ๐Ÿ‡ธ USA